TB-500 is a synthetic fragment of thymosin beta-4, studied in research for its involvement in actin sequestration and cell migration processes. Preclinical models have explored its potential in wound healing, tissue regeneration, and anti-inflammatory responses, particularly in dermal, corneal, and musculoskeletal injury simulations. It is used to investigate cellular repair pathways and angiogenesis in laboratory settings.
For research use only.
